Learn More
Chembio ProciseDx Analyzer

Description
- FDA-Cleared for Therapeutic Drug Monitoring (TDM): The only FDA-cleared system for quantitative measurement of Infliximab (IFX) and Adalimumab (ADL) drug levels in human serum—supporting therapeutic management in adult and pediatric IBD patients.
- Rapid Turnaround Time: Delivers quantitative results in under 5 minutes from sample insertion—enabling timely clinical decision-making and eliminating the delays of send-out testing.
- Streamlined Workflow for Clinical Labs: Minimal hands-on time (~3 minutes) and no batching required. Simple, standardized protocol fits easily into daily operations with no calibration, no daily maintenance, and no special service contracts.
- Compact, Bench-Top Design: Small footprint allows the ProciseDx Analyzer to fit seamlessly into hospital labs, specialty reference labs, and clinical testing sites without disrupting existing workflows.
- High Precision and Proprietary Technology: Utilizes time-resolved fluorescence energy transfer (TR-FRET) for accurate, reproducible results. Delivers performance comparable to laboratory-developed methods (LDTs) in a validated, FDA-cleared format.
- Supports Both Adult and Pediatric IBD Patients: Validated for use in both populations, ensuring broad clinical applicability across a range of GI care settings.
- Full System Offering: Includes the ProciseDx™ Analyzer and FDA-cleared Procise IFX and ADL assays. Each component is designed to work together as a fully integrated platform.
Specifications
Specifications
| Type | Clinical Chemistry Analyzer |
| Sample Type | Serum |
| Shipping Condition | -4°F to +131°F (-20°C to +55°C) |
| Voltage | 100/240 V |
| Weight (English) | 10 lb. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.